Validate ubiquitylation-dependent UBQLN2 turnover as actionable driver in ALS

Test whether UBQLN2 mutations cause ALS through disrupted ubiquitylation-dependent turnover. If true, mapping E3 ligases and perturbing UBQLN2 puncta lifetime should shift disease progression in ALS models.